Nonalcoholic fatty liver disease in diabetes. Part I

Epidemiology and diagnosis

Yong ho Lee, Yongin Cho, byungwan lee, Cheol Young Park, Dae Ho Lee, Bong Soo Cha, Eun Jung Rhee

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Nonalcoholic fatty liver disease (NAFLD) and diabetes are common metabolic disorders whose prevalence rates are expected to rise worldwide, corresponding to aging and increasingly obese populations. Compared to the general population (around 25%), 50% to 70% of people with diabetes have NAFLD, and NAFLD severity (including fibrosis) tends to be worsened by the presence of diabetes. NAFLD is considered an emerging risk factor for type 2 diabetes mellitus and a contributor to the development of chronic diabetes-related complications. This reciprocal relationship demonstrates the importance of confirming suspected NAFLD in patients with diabetes. Due to the invasive nature of liver biopsy to assess NAFLD status, various alternative non-invasive modalities have been developed and validated. Here, we summarized the epidemiology of NAFLD in patients with diabetes and reviewed currently available imaging modalities and biomarker-based prediction models for their ability to detect liver steatosis and/or fibrosis.

Original languageEnglish
Pages (from-to)31-45
Number of pages15
JournalDiabetes and Metabolism Journal
Volume43
Issue number1
DOIs
Publication statusPublished - 2019 Feb 1

Fingerprint

Epidemiology
Fatty Liver
Diabetes Complications
Non-alcoholic Fatty Liver Disease
Liver Cirrhosis
Type 2 Diabetes Mellitus
Population
Fibrosis
Biomarkers
Biopsy
Liver

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism

Cite this

Lee, Yong ho ; Cho, Yongin ; lee, byungwan ; Park, Cheol Young ; Lee, Dae Ho ; Cha, Bong Soo ; Rhee, Eun Jung. / Nonalcoholic fatty liver disease in diabetes. Part I : Epidemiology and diagnosis. In: Diabetes and Metabolism Journal. 2019 ; Vol. 43, No. 1. pp. 31-45.
@article{da5dd85271ed48f5b79fcc89e9467ce4,
title = "Nonalcoholic fatty liver disease in diabetes. Part I: Epidemiology and diagnosis",
abstract = "Nonalcoholic fatty liver disease (NAFLD) and diabetes are common metabolic disorders whose prevalence rates are expected to rise worldwide, corresponding to aging and increasingly obese populations. Compared to the general population (around 25{\%}), 50{\%} to 70{\%} of people with diabetes have NAFLD, and NAFLD severity (including fibrosis) tends to be worsened by the presence of diabetes. NAFLD is considered an emerging risk factor for type 2 diabetes mellitus and a contributor to the development of chronic diabetes-related complications. This reciprocal relationship demonstrates the importance of confirming suspected NAFLD in patients with diabetes. Due to the invasive nature of liver biopsy to assess NAFLD status, various alternative non-invasive modalities have been developed and validated. Here, we summarized the epidemiology of NAFLD in patients with diabetes and reviewed currently available imaging modalities and biomarker-based prediction models for their ability to detect liver steatosis and/or fibrosis.",
author = "Lee, {Yong ho} and Yongin Cho and byungwan lee and Park, {Cheol Young} and Lee, {Dae Ho} and Cha, {Bong Soo} and Rhee, {Eun Jung}",
year = "2019",
month = "2",
day = "1",
doi = "10.4093/dmj.2019.0011",
language = "English",
volume = "43",
pages = "31--45",
journal = "Diabetes and Metabolism Journal",
issn = "2233-6079",
publisher = "Korean Diabetes Association",
number = "1",

}

Nonalcoholic fatty liver disease in diabetes. Part I : Epidemiology and diagnosis. / Lee, Yong ho; Cho, Yongin; lee, byungwan; Park, Cheol Young; Lee, Dae Ho; Cha, Bong Soo; Rhee, Eun Jung.

In: Diabetes and Metabolism Journal, Vol. 43, No. 1, 01.02.2019, p. 31-45.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Nonalcoholic fatty liver disease in diabetes. Part I

T2 - Epidemiology and diagnosis

AU - Lee, Yong ho

AU - Cho, Yongin

AU - lee, byungwan

AU - Park, Cheol Young

AU - Lee, Dae Ho

AU - Cha, Bong Soo

AU - Rhee, Eun Jung

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Nonalcoholic fatty liver disease (NAFLD) and diabetes are common metabolic disorders whose prevalence rates are expected to rise worldwide, corresponding to aging and increasingly obese populations. Compared to the general population (around 25%), 50% to 70% of people with diabetes have NAFLD, and NAFLD severity (including fibrosis) tends to be worsened by the presence of diabetes. NAFLD is considered an emerging risk factor for type 2 diabetes mellitus and a contributor to the development of chronic diabetes-related complications. This reciprocal relationship demonstrates the importance of confirming suspected NAFLD in patients with diabetes. Due to the invasive nature of liver biopsy to assess NAFLD status, various alternative non-invasive modalities have been developed and validated. Here, we summarized the epidemiology of NAFLD in patients with diabetes and reviewed currently available imaging modalities and biomarker-based prediction models for their ability to detect liver steatosis and/or fibrosis.

AB - Nonalcoholic fatty liver disease (NAFLD) and diabetes are common metabolic disorders whose prevalence rates are expected to rise worldwide, corresponding to aging and increasingly obese populations. Compared to the general population (around 25%), 50% to 70% of people with diabetes have NAFLD, and NAFLD severity (including fibrosis) tends to be worsened by the presence of diabetes. NAFLD is considered an emerging risk factor for type 2 diabetes mellitus and a contributor to the development of chronic diabetes-related complications. This reciprocal relationship demonstrates the importance of confirming suspected NAFLD in patients with diabetes. Due to the invasive nature of liver biopsy to assess NAFLD status, various alternative non-invasive modalities have been developed and validated. Here, we summarized the epidemiology of NAFLD in patients with diabetes and reviewed currently available imaging modalities and biomarker-based prediction models for their ability to detect liver steatosis and/or fibrosis.

UR - http://www.scopus.com/inward/record.url?scp=85063409633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063409633&partnerID=8YFLogxK

U2 - 10.4093/dmj.2019.0011

DO - 10.4093/dmj.2019.0011

M3 - Review article

VL - 43

SP - 31

EP - 45

JO - Diabetes and Metabolism Journal

JF - Diabetes and Metabolism Journal

SN - 2233-6079

IS - 1

ER -